sector

Wal-Mart increases annual dividend by 21%

wal-mart, walmart, store, retail, sector, wmt, nyse, dividend, profit, net, gross, gain, earn, share, stock, shareholder, stockholder, quarter, year, financial, finance, business, sale, revenue, fiscal

The Board of Wal-Mart has approved an annual dividend of $1.46 per share, a 21% increase from the $1.21 per share paid during FY11. For the current fiscal year ending Jan. 31, 2012, the annual dividend of $1.46 per share will be p

By Stephanie Shyu
sshyu@fnno.com

Consumer Sector Report: February 17th, 2011

Weight Watchers International (WTW) is up a whopping 20% on its 2010 Q4 results. At last check, it's up to $54.40, much higher than its 52-week high of $44.93.

The company reported Q4 revs of $356.7 mln, well ahead of the analyst consensus of $321 mln on Thomson Reuters. EPS was $0.66, vs. expectations of $0.56 per
share.

For 2011, the company is guiding for EPS of $3.50 to $3.85 per share, vs. the Street view of $2.77 per share.

consumer, sector, build-a-bear, bbw, nyse, weight watchers, wtw, q4, shares, stock, trade, wall street, news, business, earnings, spend

Consumer shares are moving into positive territory this morning, albeit slightly.

By Stephanie Shyu
sshyu@fnno.com

Dr Pepper Snapple Group Topped Q4 Estimates, Top Line Up 4%

The company sees 2011 EPS of $2.70 to $2.78, vs. consensus estimates of $2.73 per share, on revenues of about $5.81 to $5.92 billion, vs.

Larry Young, dps, nyse, stock, ceo, cfo, finance, financial, statement, quarter, q4, earnings, dr pepper, snapple, soda, made from the greatest stuff on earth, drink, sector, consumer, eps, revenue, margin, gross,

Dr Pepper Snapple Group (NYSE:DPS) reported Q4 EPS of $0.67, ahead of consensus estimates of $0.64 per share. Revenues for the quarter rose 4% year-over-year to $1.41 billion, topping consensus estimates of $1.40 billion.

By Stephanie Shyu
sshyu@fnno.com

Equinix Tops Q4 Sales and EPS Estimates

The company sees Q1 sales of $354-$356 million vs a Street target of $354 million. Gross margins are expected to be approximately 64%.

market, share, eps, earning, revenue, roi, return, invest, advice, analyst, ceo, executive, cfo, finance, financial, buy, sell, stock, share, market, sector, industry, quarter, year, estimate, consensus, wall street

Equinix (NASDAQ:EQIX) reported Q4 EPS of 29 cents, topping consensus estimates of 23 cents. Revenue totaled $345.2 million, inline with Street estimates.

By Christie Duffy
cduffy@fnno.com

Cisco Tops Q2 Estimates, But Shares Fall

Cisco reported adjusted inventory turns of 10.0 and days sales outstanding of 40 days. That is is up from 38 days during Q1.

Chairman and CEO John Chamber said, "The quarter played out as we expected. Our strategy of tightly integrating our multiple products through an architectural approach is working, and we are delivering innovation in each major pro

market, share, eps, earning, revenue, roi, return, invest, advice, analyst, ceo, executive, cfo, finance, financial, buy, sell, stock, share, market, sector, industry, quarter, year, estimate, consensus, wall street

Cisco (NASDAQ:CSCO) reported fiscal Q2 EPS of 37 cents, topping consensus estimates of 35 cents. Sales in the quarter totaled $10.41 billion, above the Street estimate of $10.24 billion.

By Christie Duffy
cduffy@fnno.com

Morgan Stanley Adjusted Its 2011, 2012 EPS Estimates For OpenTable, Maintained Its EW Rating

The bank sees 2011 EPS of $0.77, down from $0.86 per share, and 2012 EPS of $1.28, up from $1.12 per share.

OpenTable is currently above its 50-day moving average (MA) of $75.14 and above its 200-day of $57.89.

opentable, restaurant, reservation, buy, sell, stock, trade, invest, roi, return, margin, profit, revenue, analyst, upgrade, downgrade, price, target, market, sector, industry, rating, report, research, eps, moving average, morgan stanley, NASDAQ:OPEN

Morgan Stanley adjusted its 2011 and 2012 EPS estimates for OpenTable (NASDAQ:OPEN) and maintained its equal-weight rating.

By Christie Duffy
cduffy@fnno.com

Teva Pharmaceuticals Down 0.9% Despite Positive Results from Phase III Trial of Rhinits Drug

Teva said results from a Phase III study of QNAZE HFA, its nasal aerosol corticosteroid in development to treat perennial allergic rhinitis (PAR) and seasonal allergic rhinitis, achieved all primary and secondary efficacy endpoint

Teva shares are down 0.9%, or $0.46, to $51.56.

teva, pharmaceutical, pill, drug, test, trial, fda, review, government, approval, patient, cure, aid, sick, allergy, share, trade, stock, sector, industry, analyst, phase, rhinits

Teva Pharmaceuticals (TEVA) shares are down fractionally, despite positive drug trial news.

By Christie Duffy
cduffy@fnno.com

Stratasys Shares up 11.30% on 80% Increase in Q4 Profit

The company posted record revenue of $33.8 million for the fourth quarter ended Dec. 31, a 29% increase over the $26.2 million reported for the same period in 2009. Net income was $4.3 million for the fourth quarter, or $0.20 per

advice, analyst, average, balance, bank, billion, business, company, down, downgrade, earnings, economy, eps, estimate, expecton billion quarter year fiscal finance business economy roi return invest advice balance sheet net income gross margin result report research analyst firm bank company stock share trade up down upgrade downgrade trend percent industry sector average, finance, firm, fiscal, gross, income, industry, invest, margin, million, net, percent, quarter, report, research, result, return, reuters, revenue, roi, sector, share, sheet, stock, trade, trend, up, upgrade, year

Shares of Stratasys (SSYS) are up $4.80 to $40.18, or 11.61%, after the company reported strong fourth quarter and full year financial results that surpassed market expectations.

By Christie Duffy
cduffy@fnno.com

Morgan Stanley Lowered its 2011, 2012 EPS Estimates For Teva Pharmaceutical Industries (TEVA)

teva, pharmaceutical, pills, prescription, medicine, heal, earn, buy, sell, upgrade, downgrade, share, stock, market, price, target, analyst, research, report, firm, bank, industry, sector, business, finance, invest, advice, money, dollar, million, billion, up, down, equal-weight, rating

Morgan Stanley lowered its 2011 and 2012 EPS estimates for Teva Pharmaceutical Industries (NASDAQ:TEVA) and maintained its equal-weight rating. The bank sees 2011 EPS of $5.05, down from $5.29 per share, and 2012 EPS of $5.78, do

By Christie Duffy
cduffy@fnno.com

Pegasystems Launches New Healthcare Systems Solutions

Revenue Cycle Manager enables error correction at every stage, unlike legacy applications that resolve errors at the end-stages of the revenue cycle, or point solutions that take limiting approaches at some stages, the company sai

Shares are down 0.36% or $38.47.

pega, system, tech, processor, micro, technology, sector, industry, earn, listing, stock, price, target, trade, buy, sell, invest, money, advice, analyst, gross, margin, net, income, revenue, eps, healthcare, patient, hospital, doctor, invoice, bill, records, computer, issue, cash, cost

Pegasystems (PEGA) today announced the launch of its new Revenue Cycle Manager solution for the health care market, which it says allows health care systems to streamline patient billing, boost cash flow and drive down operational

By Christie Duffy
cduffy@fnno.com

Latest News from FNNO

Earnings Look Back: Comcast Is Up 3.1% S...

When Comcast (NASDAQ:CMCSK) reported earnings 17 days ago on May 1st, 2013, analysts, o ...

Earnings Flashback: Since Reporting Quar...

A week ago on May 6th, 2013 Liberty Global (NASDAQ:LBTYA) reported earnings and analyst ...

Earnings Look Back: Kelly Services Is Up...

When Kelly Services (NASDAQ:KELYA) reported earnings a week ago on May 8th, 2013, analy ...

Liberty Media Earnings Review: 10 Days a...

When Liberty Media (NASDAQ:LINTA) reported earnings a week ago on May 8th, 2013, analys ...

Central Garden and Pet Earnings Hindsigh...

A week ago on May 8th, 2013 Central Garden and Pet (NASDAQ:CENTA) reported earnings and ...

Comcast Earnings Review: 17 Days after A...

When Comcast (NASDAQ:CMCSA) reported earnings 17 days ago on May 1st, 2013, analysts, o ...

Earnings Flashback: Since Reporting Quar...

A week ago on May 7th, 2013 Discovery Communications (NASDAQ:DISCA) reported earnings a ...

Jazz Pharmaceuticals Earnings In Retrosp...

11 days ago, on May 7th, 2013, Jazz Pharmaceuticals (NASDAQ:JAZZ) reported its earnings ...

Most Popular Video News